In the course of a recently concluded trial over a medical imaging dye called Omniscan, witnesses claimed that manufacturer GE Healthcare actively tried to suppress evidence that the dye could be dangerous, ProPublica reports.
A jury in Cleveland recently awarded $4.5 million to the plaintiff – a 61-year-old man diagnosed with a disease called nephrogenic systemic fibrosis in 2010 — and $500,000 to his wife. Prior to that trial, GE had ...
continue reading...